3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
8
Withdrawn
3
Terminated
2
Recruiting
2
Not yet recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Skin Diseases
1
Neoplasms by Site
1
Neoplasms
1
Breast Neoplasms
1
Breast Diseases
1
Interventions
Cisplatin
509
Cyclophosphamide
360
Carboplatin
352
Radiotherapy
350
Capecitabine
329
Paclitaxel
325
Oxaliplatin
324
Gemcitabine
319
Docetaxel
311
Fluorouracil
284
Drug Therapy
244
apatinib
242
Bevacizumab
230
camrelizumab
214
Etoposide
200
Irinotecan
177
Doxorubicin
175
Leucovorin
162
Dexamethasone
160
sintilimab
142
pembrolizumab
140
anlotinib
136
Pemetrexed
136
Cytarabine
136
toripalimab
129
Neoadjuvant Therapy
122
S 1 (combination)
120
Vincristine
119
Rituximab
117
Radiosurgery
117
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Botulinum Toxins, Type A
×
Clear all
NCT01427400
2016-07-29
Botox
University of British Columbia
Phase 4
Unknown
128 enrolled